D. Alison

发表

Cerebral metastasis and other cerebral events in women with ovarian cancer.

J. Spencer, B. Carrington, A. Sanderson, 2002, Clinical radiology.

Ploidy, proliferative activity, cluster differentiation antigen expression and clinical remission in highgrade non‐Hodgkin's lymphoma

P. Quirke, C. Bird, J. Child, 1987, Histopathology.

Palliative care activity in a medical oncology unit: the implications for oncology training.

M. Kiely, D. Alison, 2000, Clinical oncology (Royal College of Radiologists (Great Britain)).

Pharmacokinetics of the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) in the mouse.

P. O'Connor, D. Newell, A. Calvert, 1986, Cancer treatment reports.

Guidelines for managing cancer pain in adults

D. Alison, 1995 .

Cluster differentiation antigen expression, proliferative activity and clinical stage in centroblastic centrocytic lymphomas

P. Quirke, C. Bird, J. Child, 1986, The Journal of pathology.

Prognosis in low grade non‐Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin level

D. Parker, J. Child, D. Norfolk, 1994, Hematological oncology.

“Non invasive neck exploration”: The value of I 123 dual isotope parathyroid subtraction SPECT/CT in the diagnosis and localisation of parathyroid adenomas D.Alison SpR Radiology, Singleton Hospital GR Tudor, Radiology, Princess of Wales Hospital G.Middleton, Radiology, Princess of Wales Hospital

D. Alison, 2012 .

The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717)

D. Newell, A. Calvert, S. Harland, 2004, Cancer Chemotherapy and Pharmacology.

What's new in oncology: targeted therapy

E. Takeuchi, D. Alison, 2008 .